← Back to Search

Exparel pudendal block for Vaginal Prolapse

Phase 4
Waitlist Available
Research Sponsored by Atlantic Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 24 hours before surgery and 72 hours post operative
Awards & highlights

Study Summary

Pudendal Block Using Liposomal Bupivacaine vs. Standard Treatment During Sacrospinous Ligament Fixation

Eligible Conditions
  • Vaginal Prolapse

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~daily post-op days 1-3 and 7
This trial's timeline: 3 weeks for screening, Varies for treatment, and daily post-op days 1-3 and 7 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain on postoperative day one
Secondary outcome measures
Ambulatory Quality of Life questionnaire (QoR)
Average pain each day
Most intense pain each day
+6 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Exparel pudendal blockExperimental Treatment1 Intervention
This group will have intra-operative pudendal block performed with Liposomal Bupivacaine (EXPAREL) solution.
Group II: Comparison groupActive Control1 Intervention
This group will be those to receive current standard treatment with no pudendal block performed.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Bupivacaine
FDA approved

Find a Location

Who is running the clinical trial?

Atlantic Health SystemLead Sponsor
52 Previous Clinical Trials
6,199 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Pudendal Block Using Liposomal Bupivacaine vs. Standard Treatment During Sacrospinous Ligament Fixation
Ricardo Caraballo, MD 2018. "Pudendal Block Using Liposomal Bupivacaine vs. Standard Treatment During Sacrospinous Ligament Fixation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03664986.
All > Exparel
~13 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top